BioCina is a multiservice biologics CDMO headquartered in Thebarton, South Australia. BioCina specializes in the development and GMP manufacture of microbial-based biological pharmaceuticals, such as proteins and pDNA- and mRNA-based vaccines and therapeutics. The company has robust mRNA services including process development, analytical development, tech transfer, and end-to-end GMP manufacturing of LNP-encapsulated mRNA. They are capable of developing processes up to 1-L IVT and 1-L LNP encapsulation scale, and can manufacture large-scale clinical and commercial mRNA up to 10 L.
